Oncogenic AURKA-enhanced N6-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells. (2021)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41422-020-00397-2
PubMed Identifier: 32859993
Publication URI: http://europepmc.org/abstract/MED/32859993
Type: Journal Article/Review
Volume: 31
Parent Publication: Cell research
Issue: 3
ISSN: 1001-0602